Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
MobileODT logo — A FemTech company. Creating a new paradigm in cervical canc...

MobileODT

A FemTech company. Creating a new paradigm in cervical cancer screening and treatment.

Founded 2017 Israel Israel 13 employees Series C Total: $14.13M AI, Biotechnology +3

General Information

Company Name MobileODT
Founded Year 2017
Location Israel Israel
Founders / Decision Makers
Team member
Employees 13
Industries AI, Biotechnology, Health Care +2
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with MobileODT. To contact MobileODT, visit mobileodt.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MobileODT compare?

A PDF of MobileODT and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MobileODT soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MobileODT

MobileODT, **founded in 2012**, is a biotechnology and healthcare startup with the slogan "Empowering healthcare providers everywhere with smart, connected visual diagnostic tools, improving access, reducing costs, and enhancing outcomes." The company has developed the Enhanced Visual Assessment (EVA) System, **garnering a $4.00M Series C investment on 12 August 2020** from notable investors including **Laerdal Million Lives Fund, OrbiMed, Tara Health Foundation, and Tristel**. EVA, an FDA-cleared mobile colposcope, has gained significant market share in the US, Africa, and India, with over 40,000 procedures conducted across 29 countries. Notably, **leading hospitals such as MD Anderson, Mount Sinai, and Apollo** utilize EVA, and the system is increasingly becoming a standard tool for visualization in the United States, with **over 20% of hospitals in New York State** offering Sexual Assault Forensic Examinations employing it. The company is rapidly expanding into new regions and developing visual-based applications for ENT, oral disease, and skin, signaling promising growth in the biotech and healthcare sectors.

Business keywords: visual diagnostic tools, connected medical devices, FDA-cleared devices, telemedicine, global healthcare, hospital equipment, medical imaging, healthcare accessibility, patient outcomes, medical innovation, expanding markets, internet-connected devices, global health impact, digital health solutions

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $4.00M 4
Laerdal Million Lives Fund OrbiMed Tara Health Foundation
Laerdal Million Lives Fund, OrbiMed +2
12 Aug 2020
Series B Undisclosed 1
VU Venture Partners
VU Venture Partners
11 Feb 2020
Series B $6.85M 2
OrbiMed
OrbiMed, Tristel
05 Jul 2017
Grant $880.00K 2
MedTech Innovator
MedTech Innovator, Vodafone Americas Foundation
04 Aug 2015
Seed Round $2.40M 1
iVentures Asia
01 Feb 2015
Series C Undisclosed 1
ZORA Ventures
ZORA Ventures
06 Nov 2012

MobileODT Alternatives & Competitors

View All Alternatives
MobileODT vs
Digital Diagnostics
Digital Diagnostics United States

AI the Right Way

Series B
113 employees
AI, Health Care
MobileODT vs
Hubly Surgical
Hubly Surgical United States

FDA Cleared Hubly Drill: intracranial drill with SMART Auto-Stop and LED force indication designed f...

Seed
16 employees
Health Care, Medical Devices
MobileODT vs
NovaSom, Inc.
NovaSom, Inc. United States

NovaSom is a privately held diagnostic-service provider for home testing and evaluation of obstructi...

Debt Financing
54 employees
Biotechnology, Medical Devices
View all alternatives

FAQ About MobileODT

A FemTech company. Creating a new paradigm in cervical cancer screening and treatment.
MobileODT was founded in 2017.
MobileODT is headquartered in Israel.
MobileODT operates in AI, Biotechnology, Health Care, Medical Devices and Machine Learning. Its work centres on visual diagnostic tools, connected medical devices, FDA-cleared devices and telemedicine.
MobileODT has approximately 13 employees.
MobileODT has completed 6 funding rounds, raising a total of $14.13M. The latest funding stage is Series C.
Top alternatives and competitors to MobileODT include Digital Diagnostics , Hubly Surgical, NovaSom, Inc., Rijuven, AgaMatrix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MobileODT and Digital Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MobileODT, https://bouncewatch.com/company/mobileodt, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes